Samsung Bioepis

Pharma

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

China approved the world's first commercial brain-computer interface. AZ expands cell therapy capabilities in China. Astellas ended a bispecific deal.

Angus Liu Mar 20, 2026 8:00am

Sandoz expands biosimilar collaboration with Samsung Bioepis

Mar 18, 2026 11:05am

drug prices biologics drug costs IRA money cash payment co-pay

Inside the turning tides of the US biosimilar market

Jan 8, 2026 9:00am

Takeda, Innovent-Lilly, Roche—Fierce Pharma Asia

Oct 31, 2025 8:20am

Pfizer CEO, Otsuka, Novartis-MSN—Fierce Pharma Asia

Jun 13, 2025 9:18am

Pfizer, Alzheimer's blood test, Samsung—Fierce Pharma Asia

May 23, 2025 9:00am